Why “American Patients First” is likely to raise drug prices outside of the United States

Background: The Trump administration’s ‘American Patients First’ blueprint proposes to reduce drug prices in the USA by increasing drug prices abroad, ex USA. The possibility of the Trump administration to raise drug prices ex USA through legal action via the WTO and bilateral negotiations with fore...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabbous, Monique, Milea, Cyprien, Simoens, Steven, François, Clement, Dussart, Claude, Chachoua, Lylia, Borissov, Borislav, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713089/
https://www.ncbi.nlm.nih.gov/pubmed/31489151
http://dx.doi.org/10.1080/20016689.2019.1650596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713089/
https://www.ncbi.nlm.nih.gov/pubmed/31489151
http://dx.doi.org/10.1080/20016689.2019.1650596

Ejemplares similares